Iron Nanoparticles Could Revolutionize Treatment for Global Iron Deficiency

Iron deficiency affects around two billion people globally, causing symptoms from fatigue to hair loss. Many struggle with traditional supplements due to unpleasant side effects like nausea or constipation. Now, researchers at ETH Zurich have developed a new approach using iron nanoparticles to improve absorption and reduce discomfort. Iron deficiency remains a widespread issue, with one in five women in Europe alone experiencing its effects. Symptoms range from muscle weakness and dizziness to cognitive impairments and brittle nails. Even without anaemia, latent deficiency can lead to headaches and hair loss.

Traditional iron supplements often come with side effects, including bloating and constipation. These issues can discourage people from taking them consistently. Lower doses help reduce side effects but may not provide enough iron for those in need. ETH Zurich's solution involves iron nanoparticles, which early clinical trials show are absorbed nearly twice as effectively as standard supplements. The technology has been patented, and the team plans to expand its use for other essential minerals like zinc, iodine, and selenium. However, further research is required before the first nanoparticle-based iron supplement reaches the market.

The new nanoparticle approach could offer a more efficient way to combat iron deficiency with fewer side effects. While the technology is promising, additional studies will determine its readiness for public use. If successful, it may also improve supplementation for other vital nutrients in the future.